MedTrace Logo

Phase IV Study of Tarceva in Patients With Advanced Stage IIIB/ IV Non-small Cell Lung Cancer (NSCLC)

NCT01951755 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2014-12-08

No results posted yet for this study

Summary

An open-label, non randomized clinical trial of Tarceva as single agent in progressed non-small cell lung cancer patients.

Conditions

Sponsors & Collaborators

  • University of Athens

    lead OTHER

Principal Investigators

  • KOSTAS N SYRIGOS, MD, PhD · Oncology Unit University of Athens, Sotiria Hosp, 152 Mesogion Av

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01951755 on ClinicalTrials.gov